HEVADEX Applications
ActiveSummary
HEVADEX Applications has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €288,685. Equity is growing by ~33.1% per year across the filed fiscal years. Its solvency ranks better than 61% of 9534 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
08-01
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
30-06
Financial
Equity above €1mEq €1.1m ▲31.1%
7 profitable years in a row build equity to €1.1m.
10-01
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
04-01
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
30-06
Financial
Equity above €500,000Eq €591,001 ▲19.4%
5 profitable years in a row build equity to €591,001.
05-01
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
04-01
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-06
Financial
Highest result since 2019net €331,274 ▲94.2%
Operating result €449,104, net result €331,274, both a record.
11-01
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-06
Financial
Equity above €200,000Eq €270,480 ▲171%
2 profitable years in a row build equity to €270,480.
13-01
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
29-01
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
30-01
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2016
28-12
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.